Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its Variation in relation to aging, lactacystin and 6-OHDA insults

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 14085-14104

  Xia, Yi ^a   Chen, Bei Yu ^b   Sun, Xiao Long ^a   Duan, Li ^a   Gao, Guo Dong ^a   Wang, Jing Jie ^a   Yung, Ken Kam Lin ^c   Chen, Liang Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Neurodegeneration; Parkinson's disease; Pro neurotrophin receptors; Pro neurotrophins

Indexed keywords

CALBINDIN; CASPASE 3; LACTACYSTIN; NERVE GROWTH FACTOR; OXIDOPAMINE; SORTILIN; TYROSINE 3 MONOOXYGENASE;

AGED; AGING; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL LOSS; COMPLEX FORMATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; WESTERN BLOTTING;

ACETYLCYSTEINE; ADAPTOR PROTEINS, VESICULAR TRANSPORT; AGING; ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; DOPAMINERGIC NEURONS; NERVE GROWTH FACTOR; OXIDOPAMINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84880166909     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140714085     Document Type: Article

References (55)

1. Fernandez-Espejo, E. Pathogenesis of Parkinson's disease: Prospects of neuroprotective and restorative therapies. Mol. Neurobiol. 2004, 29, 15-30.
2. Rangasamy, S.B.; Soderstrom, K.; Bakay, R.A.; Kordower, J.H. Neurotrophic factor therapy for Parkinson's disease. Prog. Brain Res. 2010, 184, 237-264.
3. Yacoubian, T.A.; Standaert, D.G. Targets for neuroprotection in Parkinson's disease. Biochim. Biophys. Acta 2009, 1792, 676-687.
4. Chen, L.W.; Zhang, J.P.; Shum, D.K.Y.; Chan, Y.S. Localization of NGF, NT3 and GDNF in nestin-expressing reactive astrocytes in the caudate-putamen of MPTP-treated C57/BL mice. J. Comp. Neurol. 2006, 497, 898-909.
5. Chung, E.K.; Chen, L.W.; Chan, Y.S.; Yung, K.K. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. J. Comp. Neurol. 2008, 511, 421-437.
6. Wu, J.; Yu, W.; Chen, Y.; Su, Y.; Ding, Z.; Ren, H.; Jiang, Y.; Wang, J. Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model. Neurochem. Res. 2010, 35, 495-502.
7. Chen, L.W.; Yung, K.K.; Chan, Y.S.; Shum, D.K.; Bolam, J.P. The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson's disease. CNS Neurol. Disord. Drug Targets 2008, 7, 512-523.
8. Wang, Y.Q.; Bian, G.L.; Bai, Y.; Cao, R.; Chen, L.W. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Neurochem. Int. 2008, 53, 56-62.
9. Barrett, G.L. The p75 neurotrophin receptor and neuronal apoptosis. Prog. Neurobiol. 2000, 61, 205-229.
10. Dechant, G.; Barde, Y.A. The neurotrophin receptor p75(NTR): Novel functions and implications for diseases of the nervous system. Nat. Neurosci. 2002, 5, 1131-1136.
11. Fahnestock, M.; Yu, G.; Coughlin, M.D. ProNGF: A neurotrophic or an apoptotic molecule? Prog. Brain Res. 2004, 146, 101-110.
12. Nykjaer, A.; Lee, R.; Teng, K.K.; Jansen, P.; Madsen, P.; Nielsen, M.S.; Jacobsen, C.; Kliemannel, M.; Schwarz, E.; Willnow, T.E., et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427, 843-848.
13. Nykjaer, A.; Willnow, T.E.; Petersen, C.M. p75NTR-live or let die. Curr. Opin. Neurobiol. 2005, 15, 49-57.
14. Al-Shawi, R.; Hafner, A.; Chun, S.; Raza, S.; Crutcher, K.; Thrasivoulou, C.; Simons, P.; Cowen, T. ProNGF, sortilin, and age-related neurodegeneration. Ann. N.Y. Acad. Sci. 2007, 1119, 208-215.
15. Arnett, M.G.; Ryals, J.M.; Wright, D.E. Pro-NGF, sortilin, and p75NTR: Potential mediators of injury-induced apoptosis in the mouse dorsal root ganglion. Brain Res. 2007, 1183, 32-42.
16. Cuello, A.C.; Bruno, M.A. The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease. Neurochem. Res. 2007, 32, 1041-1045.
17. Di Maria, E.; Giorgio, E.; Uliana, V.; Bonvicini, C.; Faravelli, F.; Cammarata, S.; Novello, M.C.; Galimberti, D.; Scarpini, E.; Zanetti, O., et al. Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment. J. Alzheimers Dis. 2012, 29, 699-705.
18. Harrington, A.W.; Leiner, B.; Blechschmitt, C.; Arevalo, J.C.; Lee, R.; Mörl, K.; Meyer, M.; Hempstead, B.L.; Yoon, S.O.; Giehl, K.M. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl. Acad. Sci. USA 2004, 101, 6226-6230.
19. Küst, B.M.; Brouwer, N.; Mantingh, I.J.; Boddeke, H.W.; Copray, J.C. Reduced p75NTR expression delays disease onset only in female mice of a transgenic model of familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2003, 4, 100-105.
20. Griffin, R.J.; Williams, B.W.; Bischof, J.C.; Olin, M.; Johnson, G.L.; Lee, B.W. Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy. Technol. Cancer Res. Treat. 2007, 6, 651-654.
21. Hennigan, A.; O'Callaghan, R.M.; Kelly, A.M. Neurotrophins and their receptors: Roles in plasticity, neurodegeneration and neuroprotection. Biochem. Soc. Trans. 2007, 35, 424-427.
22. Al-Shawi, R.; Hafner, A.; Olson, J.; Chun, S.; Raza, S.; Thrasivoulou, C.; Lovestone, S.; Killick, R.; Simons, P.; Cowen, T. Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and aging nervous system. Eur. J. Neurosci. 2008, 27, 2103-2114.
23. Masoudi, R.; Ioannou, M.S.; Coughlin, M.D.; Pagadala, P.; Neet, K.E.; Clewes, O.; Allen, S.J.; Dawbarn, D.; Fahnestock, M. Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J. Biol. Chem. 2009, 284, 18424-18433.
24. Volosin, M.; Song, W.; Almeida, R.D.; Kaplan, D.R.; Hempstead, B.L.; Friedman, W.J. Interaction of survival and death signaling in basal forebrain neurons: Roles of neurotrophins and proneurotrophins. J. Neurosci. 2006, 26, 7756-7766.
25. Wang, Y.J.; Valadares, D.; Sun, Y.; Wang, X.; Zhong, J.H.; Liu, X.H.; Majd, S.; Chen, L.; Gao, C.Y.; Chen, S., et al. Effects of proNGF on neuronal viability, neurite growth and amyloid-beta metabolism. Neurotox. Res. 2010, 17, 257-267.
26. Nakamura, K.; Namekata, K.; Harada, C.; Harada, T. Intracellular sortilin expression pattern regulates proNGF-induced naturally occurring cell death during development. Cell Death Differ. 2007, 14, 1552-1554.
27. Rogers, M.L.; Bailey, S.; Matusica, D.; Nicholson, I.; Muyderman, H.; Pagadala, P.C.; Neet, K.E.; Zola, H.; Macardle, P.; Rush, R.A. ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex. J. Neuroimmunol. 2010, 226, 93-103.
28. Santos, A.M.; López-Sánchez, N.; Martín-Oliva, D.; de la Villa, P.; Cuadros, M.A.; Frade, J.M. Sortilin participates in light-dependent photoreceptor degeneration in vivo. PLoS One 2012, 7, e36243.
29. Sobottka, B.; Reinhardt, D.; Brockhaus, M.; Jacobsen, H.; Metzger, F. ProNGF inhibits NGF-mediated TrkA activation in PC12 cells. J. Neurochem. 2008, 107, 1294-1303.
30. Song, W.; Volosin, M.; Cragnolini, A.B.; Hempstead, B.L.; Friedman, W.J. ProNGF induces PTEN via p75NTR to suppress Trk-mediated survival signaling in brain neurons. J. Neurosci. 2010, 30, 15608-15615.
31. Coulson, E.J.; May, L.M.; Osborne, S.L.; Reid, K.; Underwood, C.K.; Meunier, F.A.; Bartlett, P.F.; Sah, P. p75 neurotrophin receptor mediates neuronal cell death by activating GIRK channels through phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 2008, 28, 315-324.
32. Bhakar, A.L.; Howell, J.L.; Paul, C.E.; Salehi, A.H.; Becker, E.B.; Said, F.; Bonni, A.; Barker, P.A. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. J. Neurosci. 2003, 23, 11373-11381.
33. Linggi, M.S.; Burke, T.L.; Williams, B.B.; Harrington, A.; Kraemer, R.; Hempstead, B.L.; Yoon, S.O.; Carter, B.D. Neurotrophin receptor interacting factor (NRIF) is an essential mediator of apoptotic signaling by the p75 neurotrophin receptor. J. Biol. Chem. 2005, 280, 13801-13808.
34. Florez-McClure, M.L.; Linseman, D.A.; Chu, C.T.; Barker, P.A.; Bouchard, R.J.; Le, S.S.; Laessig, T.A.; Heidenreich, K.A. The p75 neurotrophin receptor can induce autophagy and death of cerebellar Purkinje neurons. J. Neurosci. 2004, 24, 4498-4509.
35. Lee, R.; Kermani, P.; Teng, K.K.; Hempstead, B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294, 1945-1948.
36. Srinivasan, B.; Roque, C.H.; Hempstead, B.L.; Al-Ubaidi, M.R.; Roque, R.S. Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J. Biol. Chem. 2004, 279, 41839-41845.
37. Yune, T.Y.; Lee, J.Y.; Jung, G.Y.; Kim, S.J.; Jiang, M.H.; Kim, Y.C.; Oh, Y.J.; Markelonis, G.J.; Oh, T.H. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 2007, 27, 7751-7761.
38. Pehar, M.; Cassina, P.; Vargas, M.R.; Castellanos, R.; Viera, L.; Beckman, J.S.; Estévez, A.G.; Barbeito, L. Astrocytic production of nerve growth factor in motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. J. Neurochem. 2004, 89, 464-473.
39. Kalous, A.; Nangle, M.R.; Anastasia, A.; Hempstead, B.L.; Keast, J.R. Neurotrophic actions initiated by proNGF in adult sensory neurons may require peri-somatic glia to drive local cleavage to NGF. J. Neurochem. 2012, 122, 523-536.
40. Takamura, A.; Sato, Y.; Watabe, D.; Okamoto, Y.; Nakata, T.; Kawarabayashi, T.; Oddo, S.; Laferla, F.M.; Shoji, M.; Matsubara, E. Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways. Life Sci. 2012, 91, 1177-1186.
41. Tauris, J.; Gustafsen, C.; Christensen, E.I.; Jansen, P.; Nykjaer, A.; Nyengaard, J.R.; Teng, K.K.; Schwarz, E.; Ovesen, T.; Madsen, P., et al. Proneurotrophin-3 may induce sortilin-dependent death in inner ear neurons. Eur. J. Neurosci. 2011, 33, 622-631.
42. Teng, H.K.; Teng, K.K.; Lee, R.; Wright, S.; Tevar, S.; Almeida, R.D.; Kermani, P.; Torkin, R.; Chen, Z.Y.; Lee, F.S., et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005, 25, 5455-5463.
43. Jansen, P.; Giehl, K.; Nyengaard, J.R.; Teng, K.; Lioubinski, O.; Sjoegaard, S.S.; Breiderhoff, T.; Gotthardt, M.; Lin, F.; Eilers, A., et al. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat. Neurosci. 2007, 10, 1449-1457.
44. Bierl, M.A.; Isaacson, L.G. Increased NGF proforms in aged sympathetic neurons and their targets. Neurobiol. Aging 2007, 28, 122-134.
45. Terry, A.V., Jr.; Kutiyanawalla, A.; Pillai, A. Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats. Physiol. Behav. 2011, 102, 149-157.
46. Greferath, U.; Mallard, C.; Roufail, E.; Rees, S.M.; Barrett, G.L.; Bartlett, P.F. Expression of the p75 neurotrophin receptor by striatal cholinergic neurons following global ischemia in rats is associated with neuronal degeneration. Neurosci. Lett. 2002, 332, 57-60.
47. Provenzano, M.J.; Xu, N.; ver Meer, M.R.; Clark, J.J.; Hansen, M.R. p75NTR and sortilin increase after facial nerve injury. Laryngoscope 2008, 118, 87-93.
48. Capsoni, S.; Brandi, R.; Arisi, I.; D'Onofrio, M.; Cattaneo, A. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model. CNS Neurol. Disord. Drug Targets 2011, 10, 635-647.
49. Cuello, A.C.; Bruno, M.A.; Allard, S.; Leon, W.; Iulita, M.F. Cholinergic involvement in Alzheimer's disease A link with NGF maturation and degradation. J. Mol. Neurosci. 2010, 40, 230-235.
50. Counts, S.E.; Mufson, E.J. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J. Neuropathol. Exp. Neurol. 2005, 64, 263-272.
51. Ali, T.K.; Al-Gayyar, M.M.; Matragoon, S.; Pillai, B.A.; Abdelsaid, M.A.; Nussbaum, J.J.; El-Remessy, A.B. Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury. Diabetologia 2011, 54, 657-668.
52. Stoica, G.; Lungu, G.; Kim, H.T.; Wong, P.K. Up-regulation of pro-nerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy. Brain Res. 2008, 1208, 204-216.
53. Turner, B.J.; Murray, S.S.; Piccenna, L.G.; Lopes, E.C.; Kilpatrick, T.J.; Cheema, S.S. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice. J. Neurosci. Res. 2004, 78, 193-199.
54. Wang, T.; Liu, Y.Y.; Wang, X.; Yang, N.; Zhu, H.B.; Zuo, P.P. Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signaling. Acta Pharmacol. Sin. 2010, 31, 765-774.
55. Hempstead, B.L. Commentary: Regulating proNGF action: Multiple targets for therapeutic intervention. Neurotox. Res. 2009, 16, 255-260.